A lung cancer trial bolsters a long-held idea that treatment timing matters, showing a simple shift could help immunotherapy work better and extend lives.A lung cancer trial bolsters a long-held idea that treatment timing matters, showing a simple shift could help immunotherapy work better and extend lives. Read More
